Skip navigation Jump to main navigation

Applications for 2024 Columbia Summer Session programs are now open!

Close alert

Eric M. Meslin

Speaker; President and CEO of the Council of Canadian Academies

Eric M. Meslin, PhD, FRSC, FCAHS is President and CEO of the Council of Canadian Academies (CCA). Eric joined the CCA in 2016 after 25 years in university and government settings, including the previous 15 years at Indiana University where he was Founding Director of the IU Center for Bioethics, Associate Dean for Bioethics in the IU School of Medicine, and Professor of Medicine, of Philosophy, of Medical & Molecular Genetics, of Bioethics & Law, and of Public Health.

Trained in bioethics and philosophy at York University (BA) and Georgetown University (MA, PhD) he has held academic positions at the University of Toronto, University of Oxford, Sunnybrook Health Sciences Centre, University of Western Australia, and Université de Toulouse. He is Adjunct Professor at the Dalla Lana School of Public Health, University of Toronto, Senior Fellow at the PHG Foundation University of Cambridge, and 2020-2023 Mentor for the Pierre Elliot Trudeau Foundation. Meslin has published more than 200 articles and book chapters on bioethics aspects of genomics, international health, big data, and research with human participants. His policy experience includes Bioethics Research Director in the Ethical, Legal and Social Implications (ELSI) program at the National Human Genome Research Institute, and Executive Director of the National Bioethics Advisory Commission appointed by President Clinton. He has been a member of advisory committees to the World Health Organization, UNESCO, the Canadian Institutes of Health Research, the Institute of Medicine, UK Biobank, CDC, and Genome Canada.

Among his honours, he is an elected Fellow of the Royal Society of Canada (2020), the Canadian Academy of Health Sciences (2015), and The Hastings Center (2020). In 2007 he was appointed Chevalier de L’Ordre National du Mérite by the Government of France.